tirzepatide in kenya FDA Grants a New Indication for Obesity Management Lilly's tirzepatide reduces type 2

Bariatric surgery or GLP-1 medication may help patients lose weight

Learn more including current holdings here: $LLY $NVO $VKTX $GPCR $ROG.SW $ZEAL.DC $4519.JP $AMGN $PFE $AZN

In good news for those who toss and turn in the night with restless legs syndrome and their bed partners, bioelectronic technology appears to reduce the disruptive and uncontrolled movement

So you're telling me you'd rather lose bone density than change your nutrition, lifestyle and exercise habits

Semaglutide activates GLP-1 receptors throughout the digestive tract, potentially influencing gut motility and inflammation

Many other drugmakers are attempting to break this duopoly, but this may not happen anytime soon.